PAPER Salian VS, Tang X, Thompson KJ, Curran GL, Lowe VJ, Li L, Kalari KR, Kandimalla KK
SEARCH RESULTS
340304 RESULTS
PAPER Gondim FA, Fernandes JM
ALS due to c.1189 + 1G > T (splice donor) TBK1 mutation.
Amyotroph Lateral Scler Frontotemporal Degener. 2024 Oct 26;:1. PubMed.PAPER Forrest BD, Goyal NA, Fleming TR, Bracci PM, Brett NR, Khan Z, Robinson M, Azhir A, McGrath M
The Effectiveness of NP001 on the Long-Term Survival of Patients with Amyotrophic Lateral Sclerosis.
Biomedicines. 2024 Oct 16;12(10) PubMed.PAPER Takeda T, Her YR, Kim JK, Jha NN, Monani UR
A variant of the Hspa8 synaptic chaperone modifies disease in a SOD1G86R mouse model of amyotrophic lateral sclerosis.
Exp Neurol. 2024 Oct 23;:115024. PubMed.PAPER Kulkarni R, Kumari S, Dhapola R, Sharma P, Singh SK, Medhi B, HariKrishnaReddy D
Association Between the Gut Microbiota and Alzheimer's Disease: An Update on Signaling Pathways and Translational Therapeutics.
Mol Neurobiol. 2024 Oct 26; PubMed.PAPER Głowacz K, Tokarska W, Olechowska A, Wezynfeld NE, Ciosek-Skibińska P
Tuning multispectral fluorescence quantum dot-based identification of short-length amyloid β peptides by applying Cu(II) ions.
Mikrochim Acta. 2024 Oct 26;191(11):700. PubMed.PAPER Deng T, Yu W, Lü Y
Different physical exercise in the treatment of Alzheimer's disease.
Psychogeriatrics. 2024 Oct 26; PubMed.PAPER Kryukova OV, Islanov IO, Zaklyazminskaya EV, Korostin DO, Belova VA, Cheranev VV, Repinskaia ZA, Tonevitskaya SA, Petukhov PA, Dudek SM, Kost OA, Rebrikov DV, Danilov SM
Effects of Angiotensin-I-Converting Enzyme (ACE) Mutations Associated with Alzheimer's Disease on Blood ACE Phenotype.
Biomedicines. 2024 Oct 21;12(10) PubMed.PAPER Zhang Y, Lu L, Li Y, Liu H, Zhou W, Zhang L
Response Surface Methodology Optimization of Exosome-like Nanovesicles Extraction from Lycium ruthenicum Murray and Their Inhibitory Effects on Aβ-Induced Apoptosis and Oxidative Stress in HT22 Cells.
Foods. 2024 Oct 20;13(20) PubMed.PAPER Zhai Y, Li N, Zhang Y, Li H, Wu L, Wei C, Ji J, Zheng D
Identification of JAZF1, KNOP1, and PLEKHA1 as causally associated genes and drug targets for Alzheimer's disease: a summary data-based Mendelian randomization study.
Inflammopharmacology. 2024 Oct 25; PubMed.PAPER Weymouth L, Smith AR, Lunnon K
DNA Methylation in Alzheimer's Disease.
Curr Top Behav Neurosci. 2024 Oct 26; PubMed.PAPER Ali AA, Abd El-Fattah AI, Abu-Elfotuh K, Elariny HA
Corrigendum to "Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats" [Int. Immunopharmacol. 96 (2021) 107729].
Int Immunopharmacol. 2024 Oct 24;:113429. PubMed. Corrected paper.PAPER Rochais C, Lecoutey C, Lalut J, Davis A, Duval E, Gaven F, Largillière S, Née G, Corvaisier S, Sopkova de Oliveira Santos J, Since M, Freret T, Legrand R, Callizot N, Claeysen S, Boulouard M, Dallemagne P
Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease.
Eur J Med Chem. 2024 Oct 18;280:116975. PubMed.PAPER Oas H, Cook L, Schwantes-An TH, Walsh LE, Wills AM, Mata IF, Nance MA, Beck JC, Naito A, Marder K, Alcalay RN, Verbrugge J
Participant-reported personal utility of genetic testing for Parkinson's disease and interest in clinical trial participation.
NPJ Parkinsons Dis. 2024 Oct 25;10(1):202. PubMed.PAPER Senkevich K, Parlar SC, Chantereault C, Yu E, Ahmad J, Ruskey JA, Asayesh F, Spiegelman D, Waters C, Monchi O, Dauvilliers Y, Dupré N, Miliukhina I, Timofeeva A, Emelyanov A, Pchelina S, Greenbaum L, Hassin-Baer S, Alcalay RN, Gan-Or Z
Are rare heterozygous SYNJ1 variants associated with Parkinson's disease?
NPJ Parkinsons Dis. 2024 Oct 25;10(1):201. PubMed.Current Filters
No filters selected